Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Biotech’s baby boom

Nature Biotechnology volume 37, pages 502–512 (2019)Cite this article

A Publisher Correction to this article was published on 18 June 2019

This article has been updated

2018 was the year when the funding machine for privately held biotech companies went into overdrive, with mega-rounds and rapid flotations. John Hodgson brings us this deep dive.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Global amount and number of financings raised by venture capital funds, 2007–2018.
Fig. 2: Average amount venture capital raised per round in the United States, Europe and China, 2014–2018.
Fig. 3: The evolution of the A round.
Fig. 4: $100-million-plus round evolution.
Fig. 5: Private biotech company exits.
Fig. 6: Biotech is not special.

Change history

  • 18 June 2019

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Author information

Authors and Affiliations

  1. Cambridge, UK

    John Hodgson

Authors
  1. John Hodgson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John Hodgson.

Integrated supplementary information

Supplementary Figure 1 Private biotech company exits.

a, Nasdaq Biotechnology Index (annual mean), 2009–2018. b, IPOs and M&As, 2010–2018. Source: Dow Jones VentureSource, Nasdaq.

Supplementary information

Supplementary Information

Supplementary Figure 1

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hodgson, J. Biotech’s baby boom. Nat Biotechnol 37, 502–512 (2019). https://doi.org/10.1038/s41587-019-0112-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-019-0112-4

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing